$KONEF: KETAMINE ONE (OTC: KONEF | NEO: MEDI) is rapidly scaling its business to become a big player in the North American psychedelic-assisted therapy sector. Their business model incorporates a growing roster of clinics, telemedicine, contract research and digital therapeutics including novel wearable devices.
As legalization rolls out across North America, the psychedelic-assisted therapy sector is exploding with growth and ketamine clinics have arguably become the most profitable vertical in the space.